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Glomerular visceral epithelial cells (podocytes) play a critical
role in the maintenance of glomerular permselectivity. Podo-
cyte injury, manifesting as proteinuria, is the cause of many glo-
merulardiseases.Wereportedpreviously that calcium-indepen-
dent phospholipase A2 (iPLA2) is cytoprotective against
complement-mediated glomerular epithelial cell injury. Studies
in iPLA2 KO mice have demonstrated an important role for
iPLA2 in mitochondrial lipid turnover, membrane structure,
and metabolism. The aim of the present study was to employ
iPLA2 KO mice to better understand the role of iPLA2 in
normal glomerular and podocyte function as well as in glomer-
ular injury. We show that deletion of iPLA2 did not cause
detectable albuminuria; however, it resulted in mitochondrial
structural abnormalities and enhanced autophagy in podocytes
as well as loss of podocytes in aging KO mice. Moreover, after
induction of anti-glomerular basement membrane nephritis in
young mice, iPLA2 KO mice exhibited significantly increased
levels of albuminuria, podocyte injury, and loss of podocytes
compared with wild type. Thus, iPLA2 has a protective func-
tional role in the normal glomerulus and in glomerulonephritis.
Understanding the role of iPLA2 in glomerular pathophysiol-
ogy provides opportunities for the development of novel thera-
peutic approaches to glomerular injury and proteinuria.
Phospholipase A2 (PLA2)4 enzymes catalyze the cleavage of
the sn-2-ester bond of phospholipids to yield free fatty acids,
such as arachidonic acid, and lysophospholipids (1–3). Both
products represent precursors for signaling molecules that can
exert multiple biological functions. Calcium-independent
PLA2s (iPLA2s) are members of the group VI family of PLA2
enzymes (3, 4). Group VIB (iPLA2) is homologous to iPLA2
in the C-terminal catalytic domain but shows no similarities in
the N-terminal region; accordingly, iPLA2 has regulatory
properties distinct from those of iPLA2 (3, 5, 6).
Genetic ablation of iPLA2 inmice resulted in the generation
of viable progeny that demonstrated reduced growth rate as
well as cold intolerance due to impaired fat burning in brown
adipose tissue and mitochondrial dysfunction (3, 7). Several
studies showed that iPLA2 KOmice display multiple bioener-
getic dysfunctional phenotypes. For example, iPLA2 deletion
induced profound alterations in hippocampal phospholipid
metabolism and mitochondrial phospholipid homeostasis,
resulting in enlarged and degenerating mitochondria, leading
to enhanced autophagy and cognitive dysfunction (8). Another
recent study showed that genetic ablation of iPLA2 prevented
obesity and insulin resistance during high fat feeding by mito-
chondrial uncoupling and increased adipocyte fatty acid oxida-
tion (9). Taken together, these reports confirm an obligatory
role for iPLA2 in mitochondrial lipid metabolism and mem-
brane structure, perturbation of which may profoundly influ-
ence fatty acid -oxidation, oxygen consumption, energy
expenditure, and, thus, tissue homeostasis. Despite the recent
advances in studying the pathophysiological role of iPLA2 in
the brain, liver, heart, and skeletal muscles (7, 8, 10, 11), the
pathophysiological roles of iPLA2 in the kidney are poorly
understood.
Visceral glomerular epithelial cells (GECs), also known as
podocytes, are highly differentiated cells of the kidney glomer-
ulus, which play a critical role in themaintenance of glomerular
permselectivity (12–14). Podocytes have a complex morphol-
ogy that is characterized by cell bodies with projecting foot
processes, which adhere to the glomerular basement mem-
brane (GBM). The unique shape of podocytes is supported by
the actin cytoskeleton, which allows podocytes to alter their
shape dynamically (12, 15). In many renal diseases, changes in
the size and surface charge of podocytes contribute to the
development of proteinuria. Specifically, proteinuria is associ-
ated with the disruption of the foot processes with the concom-
itant transformation of the actin cytoskeleton (12–15). Thus,
the intricate structure of foot processes is central to their func-
tion of maintaining glomerular permselectivity (i.e. filtration of
plasma but restriction of proteins). Various forms of glomeru-
lonephritis, including those induced by antibody and comple-
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ment, are associated with podocyte injury, which may lead to
foot process effacement, detachment from the GBM, or apo-
ptosis, with consequent impairment of glomerular function
and permselectivity (proteinuria), and glomerulosclerosis (13,
16–18).
Previously, we characterized the expression and activity of
iPLA2 in cultured GECs and characterized themechanisms of
iPLA2 activation by complement C5b-9 (19, 20). In GECs, we
demonstrated that iPLA2 is localized at the endoplasmic retic-
ulum (ER) and mitochondria, and this localization was depen-
dent on the N-terminal region of iPLA2 (20). Complement
stimulated the activation of iPLA2, whichwasmediated via the
extracellular signal-regulated kinase and p38 pathways. Stimu-
lation of iPLA2was dependent on phosphorylation of Ser-511
and/or Ser-515 viaMNK1 (MAPK-interacting kinase 1) (20). In
addition to characterizing these signaling pathways, we showed
that overexpression of iPLA2 in cultured GECs reduced com-
plement-mediated GEC injury (19) as well as injury by tunica-
mycin, which was associated with augmentation of the ATF6
(activating transcription factor 6) pathway of the unfolded pro-
tein response in the ER (21). In other cells, such as primary
cultures of rabbit renal proximal tubules cells, knockdown of
iPLA2 expression increased lipid peroxidation and impaired
mitochondrial function (22). Likewise, knockdown of iPLA2
in C2C12 myoblasts also caused an elevation of lipid peroxida-
tion and reduction of ATP synthesis (11). Thus, the function of
iPLA2 can be cytoprotective, and depending on the cellular
context, it may involve ER stress or removal of peroxidized
phospholipid from the mitochondrial membrane, thereby pre-
serving membrane integrity.
So far, we and others have provided considerable insight into
the functions of iPLA2 in cultured cell lines, but information
on the functional role of iPLA2 in the kidney is lacking. The
aim of the present study was to employ iPLA2 KO mice to
better understand the role of iPLA2 in normal glomerular/
podocyte function and in glomerular injury.We show that dele-
tion of iPLA2 did not cause albuminuria; however, it resulted
in mitochondrial structural abnormalities and enhanced
autophagy in podocytes of aging mice. Moreover, after induc-
tion of anti-GBM nephritis in young mice, iPLA2 KO mice
exhibited significantly increased levels of albuminuria, podo-
cyte injury, and loss of podocytes comparedwithWTmice.Our
results indicate that iPLA2 has a protective functional role in
the normal glomerulus and in glomerulonephritis.
Experimental Procedures
Materials—A mouse albumin ELISA quantification kit was
purchased from Bethyl Laboratories (Montgomery, TX). The
creatinine assay kit was from Cayman Chemical Co. (Ann
Arbor,MI). Tissue culturemedia and Lipofectamine 2000 were
from Invitrogen (Burlington, Canada) andWisent (Saint-Jean-
Baptiste, Canada). Electrophoresis reagents were from Bio-Rad
(Mississauga, Canada), and GE Healthcare (Baie d’Urfé, Can-
ada). Rabbit anti-Wilms tumor-1 (WT1; catalog no. 192), goat
anti-synaptopodin (catalog no. 21537), rabbit anti-GRP94 (cat-
alog no. 11402), and rat anti-GRP78 (BiP; catalog no. 13539)
antibodies were purchased from Santa Cruz Biotechnology.
Goat anti-podocalyxin antibody (catalog no. AF1556) was from
R&D Systems (Minneapolis, MN). Rabbit anti-microtubule-as-
sociated protein light chain 3B (LC3; catalog no. 2775), rabbit
anti-phospho-AMP-activated protein kinase (AMPK)- (Thr-
172; catalog no. 2531), and rabbit anti-AMPK (catalog no.
2532) antibodies were from Cell Signaling Technology (Dan-
vers, MA). FITC-conjugated rabbit anti-sheep IgG (catalog no.
31509) was from Zymed Laboratories Inc. (South San Fran-
cisco, CA). FITC-conjugated goat anti-mouse complement C3
(catalog no. 55500) was purchased fromMP Biomedical (Santa
Ana, CA).MitoTracker Red CMXRos was fromThermo Fisher
Scientific (Burlington, ON). Plasmid pBABE-puro mCherry-
EGFP-LC3B was from Addgene (catalog no. 22418) (23). Plas-
mid “mito-YFP” (cytochrome c oxidase-subunit IV fused with
yellow fluorescent protein; catalog no. 10089272) was from the
American Type Culture Collection (Manassas, VA). Sheep
anti-rat GBM, and rabbit anti-nephrin antisera were described
previously (24, 25).
Mice—iPLA2 KOmice in a C57BL/6 background were pro-
duced, bred, and genotyped, as described previously (7). Animal
protocols were reviewed and approved by the McGill Univer-
sity Animal Care Committee. Conscious animals fed ad libitum
were weighed, and urine samples were collected at various time
points after weaning up to 12–16 months of age.
Assays for Albuminuria and SerumCreatinine—Mouse urine
albumin concentration was quantified using an enzyme-linked
immunosorbent assay kit according to the manufacturer’s
instructions. The assay utilizes urine samples diluted 1:5000 or
1:150,000, analyzed in a plate reader set at 450 nm. Urine cre-
atinine concentration was measured using a colorimetric assay
kit according to themanufacturer’s instructions.Theassaymea-
sures creatinine in urine samples diluted 1:15, using a picric
acid-based method, and analyzed on a plate reader set at 490–
500 nm. Excretion of albumin is expressed as the albumin/cre-
atinine ratio. Serum creatinine was measured using an enzy-
matic assay on the Olympus AU5822 chemistry system
(Beckman Coulter) in the Biochemistry Laboratory of the
McGill University Health Centre.
Induction of Anti-GBM Nephritis in Mice—Anti-GBM
nephritis was induced in 3–4-month-old iPLA2 KO or WT
mice by a single tail intravenous injection of 5–10 l of sheep
anti-GBM antiserum diluted in 0.1 ml of sterile saline (24, 26).
After 24 h, mice were sacrificed by CO2 asphyxiation, and kid-
neys were dissected. Kidney sections were collected for immu-
nofluorescence, light, and electron microscopy (see below).
Glomeruli were isolated utilizing a differential sieving tech-
nique (24).
Cell Culture and Complement Cytotoxicity Assay—Mouse
GECswere derived from iPLA2KOmice andWTcontrol. The
detailedmethod and characterization of the cells was published
previously (21). Briefly, by quantitative reverse polymerase
chain reaction, iPLA2mRNAwas present in cells derived from
WTmice butwas completely absent in cells fromKOmice.WT
and KO cell lines expressed the podocyte proteins, synaptopo-
din and nephrin (12, 14, 21). The cells were cultured on plastic
substratum in K1 medium and were used at passages 2–20.
Cells were transfected with pBABE-puro mCherry-EGFP-
LC3B, using Lipofectamine 2000 reagent according to theman-
ufacturer’s instructions.
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Rat GECs were cultured as described above and were char-
acterized previously (19–21, 26). These cells were employed in
the complement cytotoxicity assay (19, 20, 26). Briefly, rat
GECswere incubatedwith rabbit anti-GEC antiserum (5%, v/v)
in modified Krebs-Henseleit buffer containing 145 mMNaCl, 5
mM KCl, 0.5 mMMgSO4, 1 mM Na2HPO4, 0.5 mM CaCl2, 5 mM
glucose, and 20mMHepes, pH 7.4, for 30min at 22 °C. The cells
were then incubated for 40 min at 37 °C with normal human
serum (with full complement activity) or heat-inactivated
(decomplemented) human serum (incubated at 56 °C for 60
min) in controls. Complement-mediated cytolysis was deter-
mined by measuring lactate dehydrogenase (LDH) release (19,
26). Specific LDH release was calculated as (NSHIS)/(100
HIS), whereNS represents the percentage of total LDH released
into cell supernatants in incubations with normal serum, and
HIS represents the percentage of total LDH released in incuba-
tions with heat-inactivated serum.
Immunofluorescence Microscopy—Kidney poles were snap-
frozen using HistoPrep (Fisher Scientific, Ottawa, Canada) in
isopentane (80 °C). Cryostat sections (4 m) were cut and
stored at 80 °C. Frozen sections were then fixed in 4% para-
formaldehyde and blocked with 5% normal rabbit serum (for
sheep IgG) or goat serum (for C3) in 5%BSAor in 5%BSA alone
(for synaptopodin, podocalyxin, and nephrin antibodies). The
blocking solution was replaced with a fluorophore-conjugated
primary antibody or, alternatively, with an unconjugated pri-
mary antibody, followed by a fluorophore-conjugated second-
ary antibody. Incubations with primary antibodies ranged from
2 h to overnight (4 or 22 °C). Incubations with secondary anti-
bodies were 1 h at 22 °C. Sections were examined with a Zeiss
AxioObserver fluorescencemicroscopewith visual output con-
nected to anAxioCamdigital camera. Images ofmultiple glom-
eruli were collected from series of images derived from differ-
ent focal planes (z-stack). To allow comparisons of fluorescence
intensity, all images were taken at the same exposure. Fluores-
cence intensity was quantified using the histogram function of
Adobe Photoshop or ImageJ software (National Institutes of
Health, Bethesda,MD). Results are expressed in arbitrary units.
For WT1 immunofluorescence, frozen sections were fixed
with 4% paraformaldehyde and then immersed in 10 mmol/
liter sodium citrate, pH 6.0, for 8min at 100 °C. After cooling to
22 °C, sections were blocked with 10% normal goat serum and
were incubated with rabbit anti-WT1 antibody (4 °C, over-
night), followed by rhodamine-goat anti-rabbit IgG (22 °C, 1 h).
WT1-positive cells were quantified by visual counting.
To visualize mitochondria, cells on coverslips were incu-
bated for 15–30 min at 37 °C with MitoTracker Red CMXRos
(25 nM). Hoechst H33342 (1 g/ml) was added for the final 5
min to label nuclei. Cells were then fixed with paraformalde-
hyde. After washing, coverslips were mounted onto glass slides
and visualized with a fluorescence microscope (20).
GFP and mCherry-LC3-II puncta in cells can be readily dis-
tinguished from background fluorescence and quantified using
ImageJ software. Green and red images were separately con-
verted to grayscale. Cell contours on grayscale images were
selected with the freehand tool, and the area of the cross-sec-
tion wasmeasured. Then image histogram plots were obtained,
representing the range of pixel brightness values in each image.
The threshold intensity was set at the end of the histogram
declining slope (thereby only including the brightest fluores-
cent puncta and omitting cellular features and background).
The area of LC3-II puncta was set between 0.2 and 25m2. The
number of particles/puncta and total cross-sectional area of the
particles/puncta whose areas fell within the set range of 0.2–25
m2 were measured. Results were normalized per 1000 m2 of
cell area. The image calculator function (subtract operation)
was used to calculate themCherry-LC3-II particles/puncta that
did not colocalize with GFP-LC3-II.
Light and ElectronMicroscopy—For lightmicroscopy, kidney
tissue was fixed in formalin, and was processed and embedded
in paraffin according to conventional techniques. Sectionswere
stained with periodic acid Schiff at the Goodman Cancer
ResearchCenterHistology Facility,McGill University. Electron
microscopywas carried out at theMcGill University Facility for
Electron Microscopy Research. Briefly, kidney tissue was fixed
in 2.5% glutaraldehyde in 0.1 mol/liter sodium cacodylate
buffer containing 0.1%CaCl2, pH7.4. Sampleswerewashed and
postfixed with 1% aqueous OsO4 and 1.5% aqueous potassium
ferrocyanide. Then samples were dehydrated with serially
increasing concentrations of acetone (from 30 to 100%) and
were infiltrated with epon/acetone. Sections of 90–100 nm
were placed onto grids and stained with uranyl acetate and
Reynold’s lead. Samples were viewed with an FEI Tecnai 12
transmission electron microscope operating at an accelerating
voltage of 120 kV and equipped with an AMT XR80C CCD
camera.
Quantification of Foot Process Effacement and Glomerular
Surface Area—Randomly selected electron micrographs were
used for morphometric analysis of foot process effacement, as
described previously (27, 28), using ImageJ software. Themean
width of the foot process (FPW) was calculated according to the
formula (27), FPW  (  glomerular basement membrane
length)/(4 foot process number).
A greater foot process width value represents increased foot
process effacement. Three capillary loops from 2–3 glomeruli/
mouse were quantified, and the results from 3–5 mice/group
were pooled and analyzed. Glomerular cross-sectional surface
area was measured in light micrographs of KO and WT mice,
using ImageJ software.
Immunoblot Analysis—Lysates of isolated glomeruli (24)
were prepared in buffer containing 1% Triton X-100, 125 mM
NaCl, 10 mM Tris (pH 7.4), 1 mM EGTA, 2 mMNa3VO4, 10 mM
sodium pyrophosphate, 25 mM NaF, and protease inhibitor
mixture (Bioshop, Burlington, Canada). Equal amounts of
lysate proteins were dissolved in Laemmli buffer and were sub-
jected to SDS-PAGE under reducing conditions. Proteins were
then electrophoretically transferred onto nitrocellulose or pol-
yvinyl difluoride membranes and blocked at 22 °C for 1 h with
5% BSA in buffer containing 10 mM Tris, pH 7.5, 50 mM NaCl,
2.5 mM EDTA, and 0.05% Tween 20. The membrane was then
incubated with primary and secondary antibodies. Bands were
detected by an enhanced chemiluminescence system (GE
Healthcare, Mississauga, Canada). Quantitative densitometry
was performed using ImageJ (25).
Statistics—Data are presented as mean S.E. One-way anal-
ysis of variance was used to determine significant differences
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among groups. Where significant differences were found, indi-
vidual comparisons weremade between groups using Student’s
t test and adjusting the critical value according to Bonferroni’s
method. Student’s t test was used to determine significant dif-
ferences between two groups.
Results
iPLA2 Deletion Does Not Affect Baseline Urinary Albumin
Excretion—General phenotypic features of mice null for
iPLA2 were described previously (7, 11). In keeping with the
earlier report, modest growth retardation was visible in KO
mice after 2months of age. At 3–4months, iPLA2KOanimals
(males and females) had amean weight of 22.09 0.75 g versus
26.02  0.84 g for WT (p  0.005, n  9–10 mice/group).
There was no significant difference in weight between males
and females within the same groups. To determine whether
deletion of iPLA2 can affect glomerular permeability and
induce proteinuria, we quantified the urine albumin/creatinine
ratio. Mice at 4–7 months of age showed a low albumin/creat-
inine ratio, and there was no significant difference between KO
and WT mice (Fig. 1A). Urine albumin tended to be slightly
higher in male mice compared with females. The albumin/cre-
atinine ratio between WT and age/sex-matched KO mice did
not differ significantly up to 16 months of age (Fig. 1). Serum
creatinine values were 9.3  0.7 M in 10–12-month-old
iPLA2 KO mice and 12.1  0.9 M in WT (p  0.02; 7–8
mice/group). The lower mean value in the KO mice is consis-
tent with lower body weight. Light microscopy (periodic acid
Schiff staining) showed normal glomerular and tubular mor-
phology in bothWTandKOmice 10–12months of age (results
not shown). To confirm the visual impression, glomerular sur-
face area was measured in light micrographs of KO and WT
mice. There were no significant differences between groups
(Fig. 1B).
iPLA2 Deletion Induces Mitochondrial Damage and
Autophagy in Podocytes—Given that iPLA2 is localized in
GECs at the ER and mitochondria (20), we hypothesized that
deletion of iPLA2 may induce abnormalities in these organ-
elles. Kidneys of iPLA2KOandWTcontrolmice at age 10–11
months were examined by electron microscopy. Podocyte foot
processes appeared structurally intact in both iPLA2KOmice
(Fig. 2A) and WT controls (not shown). WT mice showed no
apparent glomerular abnormalities, and in particular, podo-
cytes showed intact cell organelles, including the ER and mito-
chondria (Fig. 2B). In contrast, some podocytes in iPLA2 KO
mice showed microvillous transformation and membrane
vesiculation, compatible with podocyte injury (Fig. 2C). The
striking observation in iPLA2 KO mice was that podocytes
showed abnormal mitochondria and the presence of
autophagic vacuoles (Fig. 2, D–I). The mitochondrial abnor-
malities were widespread and included aggregation, disruption
of membranes, and loss/rearrangement of cristae (Fig. 2, F and
H), whereas somemitochondria appeared to be undergoing fis-
sion (Fig. 2F).
We analyzed all high power electronmicrographs to quantify
damaged mitochondria and autophagosome structures in
podocytes. In 5 iPLA2 KOmice, damaged mitochondria were
observed in 54% of the micrographs, and damaged autophago-
somes were seen in 17%. Forty percent of the micrographs
showed both normal mitochondria and an absence of autopha-
gosomes (35 high power electron micrographs were examined
in total). In threeWTmice, there were no damaged mitochon-
dria nor any autophagosomes (17 electron micrographs were
examined).
It should also be noted that, unlike podocytes, mitochondria
in parietal epithelial cells, glomerular endothelial cells, and
proximal tubular epithelial cells in iPLA2 KO mice appeared
normal (Fig. 2, D, H, and J). In contrast to the mitochondria in
iPLA2 KO podocytes, the ER and nuclei appeared intact (Fig.
2, E–I). Quantification of foot process width in iPLA2 KO and
WT mice demonstrated modest but significant widening of
foot processes in the KO (Fig. 2K). Thus, deletion of iPLA2
in mice induces prominent mitochondrial abnormalities,
autophagy, and modest widening of the foot processes and
plasma membrane changes in podocytes.
iPLA2 Deletion Induces Podocyte Loss but Not ER Dysfunc-
tion in Podocytes—The above results showed that iPLA2 dele-
tion affected podocyte ultrastructure; consequently, podocyte-
associated proteins that are believed to play key roles in
maintaining ultrastructure and slit diaphragms (nephrin, syn-
aptopodin, and podocalyxin) (12, 14, 26, 29) were examined by
immunofluorescence microscopy and immunoblot analysis.
The podocyte nuclear marker, WT1, was also studied as an
index of podocyte number (12, 14, 26, 29). Kidney sections from
iPLA2 KO and WT mice (age 10–11 months) were stained
with specific antibodies. Synaptopodin, nephrin, and podoca-
lyxin showed an immunofluorescence staining pattern consis-
tent with expression in podocytes in glomeruli of iPLA2 KO
and WT mice, although the intensity of synaptopodin was
reduced in the KO (Fig. 3A). Quantification of glomerular fluo-
rescence intensity showed that synaptopodin staining was sig-
nificantly lower in iPLA2 KO glomeruli compared with WT
(Fig. 3B). Fluorescence intensities of nephrin and podocalyxin
staining did not differ significantly between WT and iPLA2
KO mouse glomeruli, although both tended to decrease in the
KO (Fig. 3, C and D).
To determine whether deletion of iPLA2 induces podocyte
loss, we quantified the number of podocyte nuclei in glomeruli
FIGURE 1. iPLA2 deletion does not alter urinary albumin excretion in
mice. A, urinary albumin/creatinine ratio. Each point represents the urine
collection of a single mouse taken at monthly intervals between 4 and 16
months (mo) of age.WTand iPLA2KOmiceweredivided intogroups accord-
ing to sex (male (M) and female (F)). There are no significant differences
among the groups. B, glomerular surface area was measured in light micro-
graphs of KO and WT mice (age 10–11 months). There were no significant
differences between groups (3 mice/group; 14–24 measurements/group).
Error bars, S.E.
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of iPLA2 KO and WT mice using WT1 immunostaining.
There was a 25% decrease in the number of WT1-positive
cells in iPLA2 KO glomeruli compared with control (Fig. 3, A
and E), indicating that deletion of iPLA2 induced a loss of
podocytes. This result does not, however, exclude the possibil-
ity that a reduction in WT1-positive cells might have been
related to injury instead of loss of cells.
Immunoblotting of glomerular lysates showed that expres-
sion of nephrin and podocalyxin proteins was not significantly
different between iPLA2KO andWTmice. Synaptopodin was
reduced in the KO (Fig. 4, A–D), consistent with the immuno-
fluorescence staining (Fig. 3, B–D). Nephrin undergoes impor-
tant post-translational modifications in the ER before export to
the plasmamembrane (25). By SDS-PAGE, nephrinmigrates as
a doublet of 180 kDa. The upper band represents the fully
glycosylated, mature form of nephrin, whereas the lower band
is an immature form found in the ER (25, 26). To address the
role of iPLA2 in ER function in vivo, we examined the pattern
of nephrin glycosylation in isolated glomeruli by immunoblot-
ting. There were no apparent differences in nephrin glycosyla-
tion between iPLA2 KO and WT mice (Fig. 4B, bottom), sug-
gesting that ER function remained intact despite iPLA2
deletion.
In a previous study (21), we demonstrated that in cultured
GECs, iPLA2, via its localization at the ER, amplified the acti-
vation of the ATF6 pathway of the unfolded protein response.
Amplification of ATF6 resulted in the up-regulation of the ER
chaperones, GRP78 (BiP) andGRP94 (21). Conversely, deletion
of iPLA2 blunted these responses, as shown in cultured GECs
derived from WT and iPLA2 KO mice (21). Therefore, we
undertook to examine the expression of ER chaperones in
podocytes in vivo by immunoblotting. Unexpectedly, there was
no significant difference in the glomerular GRP94 expression
between WT and iPLA2 KO mice (Fig. 4, A and E). A similar
result was obtained with GRP78 (BiP) expression (result not
shown). Therefore, either differences in ER chaperone expres-
sion between WT and iPLA2 KO mice were too small to be
detected in vivo, or additional factors regulate the expression of
these proteins in vivo compared with in cultured cells.
iPLA2Deletion ReducesMitochondrial Function—The elec-
tron micrographs of iPLA2 KO mice showed striking mito-
chondrial abnormalities (Fig. 2). To determine whether these
FIGURE 2.Kidney cell ultrastructure in 10–11-month-oldmice (electronmicroscopy).A, podocyte foot processes in iPLA2-KOmice appeared structurally
intact. B, podocyte from aWT, control mouse shows intact cell organelles, includingmitochondria. C, podocytes from an iPLA2 KOmouse showmicrovillous
transformation and membrane vesiculation (arrows). D–I, podocytes from iPLA2-KO mice show abnormal mitochondria and autophagic vacuoles. F and H,
magnified views of the areas in E and G outlined by boxes, respectively. Mitochondria in podocytes show aggregation, disruption of membranes, and loss of
cristae (arrowheads in F and H), whereas some mitochondria appear to be undergoing fission (F). In D and I, the closed arrows point to autophagosomes in
podocytes.Mitochondria in a parietal epithelial cell (open arrow,D) and aglomerular endothelial cell (open arrow,H) appear normal. The ER (F andH) andnuclei
(E–I) in podocytes appear intact. J, proximal tubular epithelial cell from an iPLA2-KOmouse shows normal mitochondria. The brush border is seen on the top
right of the photomicrograph. Bar, 500 nm. Glomeruli were examined in five KO and three WT mice, 2–3 glomeruli/mouse. K, quantification of foot process
width in iPLA2-KO and WTmice. *, p 0.0005 KO versusWT (21–22 measurements/group). Error bars, S.E.
FIGURE 3. Expression of synaptopodin, nephrin, podocalyxin, and WT1 in 10–11-month-old WT and iPLA2-KO mice. A, kidney sections were stained
with specific antibodies and were examined by immunofluorescence microscopy. Bar, 20 m. B–D, quantification of fluorescence intensity in arbitrary units
(3–7 glomeruli/mouse in three KO and two WT mice, or 11–18 glomeruli/group, were analyzed). B, synaptopodin: p 0.0002, KO versusWT. E, WT1-positive
(pos) nuclei: p 0.0001, KO versusWT (6–12 glomeruli/mouse in three KO and twoWTmice, or 34–55 glomeruli/group, were analyzed). Error bars, S.E.
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mitochondrial abnormalities were associated with impaired
mitochondrial function in vivo, we monitored phosphorylation
ofAMPK, a ubiquitous serine/threonine kinase (30, 31). During
periods of cellular stress, particularlywhen there is a decrease in
ATP, and increases in ADP and AMP, binding of ADP or AMP
activates AMPK by facilitating phosphorylation and inhibiting
dephosphorylation of Thr-172 in the -subunit. Thus, AMPK
acts as a sensor of cell energy stores, and phosphorylation of
AMPK is inversely related to the cell’s ATP level. The mean
glomerular phospho-AMPK level was clearly increased in
iPLA2 KO mice compared with control, although there was
some variability among animals (Fig. 4, A and F). This result is
in keeping with reduced ATP generation by mitochondria in
podocytes.
To provide additional support for the conclusion that dele-
tion of iPLA2 impaired mitochondrial function, we examined
Mitotracker Red CMXRos staining in cultured GECs produced
from WT and iPLA2 KO mice (21). MitoTracker Red
CMXRos is a fluorescent dye that stains mitochondria in live
cells, and its accumulation is dependent on the mitochondrial
membrane potential. In WT cells, the mitochondria stained
brightly and localized diffusely throughout the cytoplasm (Fig.
5, A and C). In these cells, the mitochondria appeared as short
tubular structures, and they did not form long filaments. In
most of the iPLA2 KO cells, cytoplasmic staining was faint or
absent, and the mitochondria appeared aggregated in a perinu-
clear distribution (Fig. 5, A and C). The latter resembled the
staining of Mitotracker Red CMXRos in WT GECs that had
been treated with antimycin A (Fig. 5A). This drug disrupts
mitochondrial function by blocking the electron transport
chain and results in loss of fluorescent probe from mitochon-
dria (32). It should be noted that, in contrast to theMitotracker
Red CMXRos staining, there were no differences in the expres-
sion of transfected mito-YFP (YFP targeted to mitochondria)
FIGURE 4. Effect of iPLA2deletiononexpressionof nephrin (fully glycosylated andER forms), podocalyxin, GRP94, synaptopodin (synpo), phospho-
AMPK (pAMPK), AMPK, and LC3-I and -II. Glomeruli were isolated from 10–11-month-old WT and iPLA2-KO mice. Lysates were immunoblotted, as indi-
cated.A, representative immunoblots. Thewhite lines in the top panel indicate reassembly of noncontiguous gel lanes. Therewere no adjustmentsmade to the
digital images among the lanes that would alter the information in the panels. B–G, densitometric quantification. B, C, and E, there were no significant
differences in the expression of fully glycosylated nephrin (top nephrin band), nephrin maturation (ratio of top to bottom band), podocalyxin, and GRP94
betweengroups (3–5mice/group).D, synaptopodinwas significantly lower in KOglomeruli. *,p0.05, 3mice/group. F, the ratio of phospho-AMPK/AMPKwas
significantly greater in KO glomeruli. *, p 0.04, 4 mice/group. G, the ratio of LC3-II/LC3-I was significantly greater in KO mice. *, p 0.01, 7–9 mice/group.
Because the intensity of the LC3-I band inAwas relativelyweak, the immunoblotwas repeated using a longer exposure time. This resulted in enhanced signals
in LC3-I bands, although the signals of the LC3-II bands became oversaturated. Nevertheless, the LC3-II/LC3-I ratio remained significantly elevated in the KO
mice compared with WT (results not shown). Error bars, S.E.
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between iPLA2 KO and WT GECs (Fig. 5, B and C). This
reflects similar mitochondrial mass in the two cell lines. Thus,
the reduced Mitotracker Red CMXRos staining in iPLA2 KO
GECs indicates impaired mitochondrial function.
iPLA2 Deletion Induces Autophagy in GECs—Ultrastruc-
tural examination of iPLA2 KOmice showed autophagic vac-
uoles in some podocytes (Fig. 2, C–E). The extent of lipidation
of LC3 (i.e. conversion of LC3-I to LC3-II) is widely used to
monitor autophagy, and typically, an increase in the ratio of
LC3-II to LC3-I correlates with the number of active autopha-
gosomes (33). We employed immunoblotting to monitor the
levels of LC3-I and LC3-II in glomeruli of WT and iPLA2 KO
mice (Fig. 4A). Densitometric quantification showed that the
LC3-II/LC3-I ratio was markedly greater in iPLA2 KO glom-
eruli compared withWT control (Fig. 4G). These results are in
keeping with the presence of autophagosomes in podocytes in
the electron micrographs of iPLA2 KOmice.
There are some limitations to quantifying enhanced
autophagic flux in vivo. Thus, to confirm enhanced autophagy
and the changes in LC3 in glomeruli, we measured the conver-
sion of LC3-I to LC3-II in cultured GECs fromWT and iPLA2
KO mice (21). GECs were incubated with or without chloro-
quine for 2 or 6 h. Chloroquine blocks the fusion of autophago-
somes with lysosomes, which forms autolysosomes, and there-
fore prevents autolysosomal protein degradation, allowing us to
compare the rate of autophagosome formation in WT and
iPLA2 KO GECs (33). GEC lysates were immunoblotted with
anti-LC3 antibody. Deletion of iPLA2 in cultured GECs
resulted in a significantly greater increase in the ratio of LC3-
II/LC3-I in KO cells, compared with WT, in the presence of
chloroquine at 6 h (Fig. 6A). This result is consistent with
enhanced autophagy and is in keeping with the findings in vivo
(Fig. 4G).
Conversion of LC3-I to LC3-II in cultured GECs was also
addressed by monitoring the formation of LC3-II puncta by
fluorescence microscopy (23, 33). In these experiments, GECs
were transfected with mCherry-GFP-LC3B, encoding LC3
tagged with two fluorescent proteins, mCherry and GFP.
mCherry- or GFP-LC3-I is cytoplasmic. GFP is quenched in an
acidic environment (i.e. in lysosomes), but mCherry is acid-
stable; thus, formation of GFP-LC3-II puncta reflects forma-
tion of autophagosomes, whereas mCherry-LC3-II puncta
reflect formation of autophagosomes and their fusion with
lysosomes (23, 33). In resting WT GECs, the distribution of
mCherry- and GFP-LC3-I was in a cytoplasmic pattern (Fig.
6B). Quantification confirmed the visual impression that rest-
ing cells contained relatively few puncta and that the puncta
constituted only a minimal proportion of cell area (Fig. 6C,
second columns). Increased formation of GFP-LC3-II puncta
and, to a lesser extent, mCherry-LC3-II puncta that did not
colocalize with GFP was evident in iPLA2 KO GECs even in
the absence of chloroquine (Fig. 6, B and C, first columns). The
addition of chloroquine markedly enhanced GFP-LC3-II
puncta in KO cells (Fig. 6, B and C, third column), consistent
with the formation of autophagosomes in the KO cells. Chloro-
quine slightly increased GFP-LC3-II puncta in WT cells, but
the change was not significant (Fig. 6, B and C, fourth column).
In the presence of chloroquine, prominent mCherry-LC3-II
puncta were also increased in KO cells, and most mCherry
puncta colocalized with GFP (Fig. 6B). These results reflect
LC3-II at autophagosomes and to a minor extent in lysosomes
and thus confirm enhanced autophagy in iPLA2 KO GECs.
iPLA2 Deletion Exacerbates Albuminuria in Anti-GBM
Nephritis—Our previous studies in cultured GECs demon-
strated a protective role for iPLA2 in injury induced by com-
plement (19) and tunicamycin (21). In addition, the above
experiments showed that in vivo, iPLA2 is essential to the
maintenance of podocyte integrity under basal conditions. Spe-
cifically, deletion of iPLA2 induced mitochondrial abnormal-
ities with autophagy in older mice. In the next set of experi-
ments, we examinedwhether induction of podocyte injury with
anti-GBM antibody would reveal a protective phenotype of
iPLA2 in young mice. C5b-9-induced GEC/podocyte injury
FIGURE 5. Mitochondrial function in cultured GECs. A, WT or iPLA2 KO
GECs were incubated with Mitotracker Red CMX-Ros (25 nM for 30 min). In
most WT cells, the mitochondria stained brightly and were found diffusely
throughout the cytoplasm. Inmany iPLA2 KO cells, cytoplasmic stainingwas
faint or absent, and the mitochondria were collapsed in a perinuclear distri-
bution. The latter resembled the staining ofMitotracker Red inWTpodocytes
that had been treated with antimycin A (WTA; 10 M for 30 min) to induce
mitochondrial dysfunction. Bar, 15 m. Cells showing diffuse, perinuclear,
and intermediate Mitotracker Red CMX-Ros staining patterns are quantified
in the graph (C; intermediate pattern indicates perinuclear localization but
with somediffuse staining). *,p0.0005; **,p0.0001, KO versusWT(170KO
cells and 228 WT cells). B, GECs were transiently transfected with mito-YFP.
Images were obtained after 24 h. In transfected cells, expression of mito-YFP
was comparable between KO andWT cells. The inset (C) shows quantification
of YFP fluorescence intensity in arbitrary units (a.u.) (22–30 cells/group). Error
bars, S.E.
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and proteinuria are hallmarks of heterologous mouse anti-
GBM nephritis. Anti-GBM antibody binds in part to podocyte
antigens in vivo, and heterologous phase proteinuria is abol-
ished by C6 deficiency, indicating a key role of C5b-9 (24, 34,
35). In previous studies, we determined that administration of
5–10 l of sheep anti-GBM antiserum induces mild to moder-
ate albuminuria (26). Therefore, iPLA2KO andWTmice (age
3–4 months) were injected with anti-GBM antiserum, and
additional mice in each group were injected with saline (con-
trol). Urine samples were collected just before administration
of antibody and after 24 h. Both WT and iPLA2 KO mice
developed albuminuria 24 h after induction of anti-GBM
nephritis. However, iPLA2 KO mice exhibited significantly
higher levels of albuminuria compared with WT (Fig. 7A).
Deposition of anti-GBM antibody and activation of comple-
ment were assessed by immunofluorescence microscopy.
There was prominent linear deposition of sheep anti-GBM IgG
along the glomerular capillary walls in both WT and iPLA2
KOmice (Fig. 7B). Glomerular C3 staining was slightly fainter,
compared with IgG, but was clearly present in both groups of
mice (Fig. 7B). Quantification of IgG and C3 fluorescence
intensity did not demonstrate significant differences between
the two groups (Fig. 7C). Therefore, the increased albuminuria
in iPLA2 KO mice occurred despite equal glomerular anti-
GBM antibody and C3 deposition inWT and iPLA2KOmice.
iPLA2 Deletion Enhances Podocyte Ultrastructural Abnor-
malities in Anti-GBM Nephritis—After injection of anti-GBM
antibody, glomerular and tubular morphology of WT and
iPLA2 KO mice (n  6–7 mice) appeared normal by light
microscopy; in particular, there was no inflammatory cell infil-
tration in the glomeruli (results not shown). Kidneys of albu-
minuric (anti-GBMantibody-treated) and controlmice (saline-
treated groups) were also examined by electron microscopy.
The 3-month-old saline-treated KO mice showed no apparent
glomerular abnormalities, and podocyte ultrastructure
appeared normal (Fig. 8A). Similarly, the saline-treated WT
mice showed no ultrastructural abnormalities (result not
shown). Anti-GBM-injectedWTmice showed focal abnormal-
ities in podocyte ultrastructure (Fig. 8B). Some podocyte cell
bodies appeared swollen, and there was some villous transfor-
mation and microvesiculation of the podocyte plasma mem-
branes. In most areas of the glomerulus, foot processes
appeared normal, but in other areas, there were abnormalities,
ranging from short and widened foot processes to patchy
effacement (Fig. 8B). Anti-GBM-injected iPLA2 KO mice
showed substantially more severe abnormalities in podocyte
ultrastructure. Podocyte cell bodies were swollen with fewer
organelles, and there was extensive villous transformation and
microvesiculation of the plasma membranes. Foot processes
were severelymalformed andwere effaced extensively (Fig. 8C).
However, there were no apparent abnormalities in the ultra-
structure of organelles, including mitochondria, and no appar-
ent autophagosomes. There was an absence of leukocytes in the
glomeruli. To quantify podocyte foot process effacement objec-
tively, we measured foot process width in iPLA2 KO and WT
mice in both saline- and anti-GBM-injected groups. The anti-
GBM-injected iPLA2 KO mice showed the greatest foot pro-
cess width, indicating severe foot process effacement (Fig. 8D).
Taken together, deletion of iPLA2 in anti-GBM nephritis
induced severe abnormalities in podocyte ultrastructure, which
are in keeping with the increased level of albuminuria in these
mice.
FIGURE 6.Autophagy is enhanced in iPLA2KOGECs in culture.A, deletion
of iPLA2 in GECs increases the ratio of LC3-II/LC3-I. WT or iPLA2 KO GECs
were incubatedwith orwithout chloroquine (CQ; 15M) for 2 or 6 h. Shown is
a representative immunoblot of GEC lysates. Values below the LC3 immuno-
blot indicatemean S.E. ratios of LC3-II/LC3-I in the eight groups (four exper-
iments). *, p 0.03 KO versus WT at 6 h (CQ). B, iPLA2 KO GECs in culture
showgreater numbers ofmCherry- andGFP-LC3-II puncta comparedwithWT
cells (representative fluorescencemicrographs). GECs were transiently trans-
fectedwithmCherry-GFP-LC3B (0.1g of plasmid DNA/well). After 24 h, cells
were untreated (Untr;) or treated with 15 M chloroquine (CQ;). Images
were obtained after 6 h. Bar, 25 m. The inset (KO-CQ,merged) is an enlarge-
ment of the areawithin the square. C, quantification of GFP-LC3-II puncta and
GFP-LC3-II puncta area. Results were normalized per 1000m2 of cell area. In
the bars showing the GFP  mCherry LC3-II puncta/area, the GFP and
mCherry components are above and below the white line, respectively. The
mCherry component is that which did not colocalize with GFP. *, p 0.005,
KO-untreated versusWT-untreated. **, p 0.0001, KO-CQ versusWT-CQ; p
0.0001, KO-CQ versus KO-Untr; and ***, p 0.01WT-CQ versusWT-untreated.
, p  0.002 KO-untreated versus WT-untreated; , p  0.0001 KO-CQ
versus WT-CQ and p  0.0001 KO-CQ versus KO-untreated (11–12 cells/
group). Error bars, S.E.
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iPLA2Deletion InducesMarked Podocyte Loss in Anti-GBM
Nephritis—In addition to albuminuria, glomerular injury may
be associated with loss of podocytes. To provide further evi-
dence for a cytoprotective effect of iPLA2 in vivo, we quanti-
fied the number of podocyte nuclei in glomeruli of KO andWT
mice by WT1 immunostaining. In saline-treated mice (age 3
months), deletion of iPLA2 did not alter the number of WT1-
positive cells compared with WT. Furthermore, in WT mice,
injection of anti-GBM antiserum did not alter the number of
WT1-positive cells. In contrast, there was a 60% decrease in
the number ofWT1-positive cells in iPLA2KOglomeruli after
anti-GBM antiserum injection (Fig. 9, A and B). Therefore,
genetic ablation of iPLA2 induced a marked loss of podocytes
after these cells were subjected to injury. Taken together, the
results indicate that iPLA2 exerts a cytoprotective effect on the
podocyte and glomerular injury in vivo.
Effects of iPLA2 Deletion on Expression of Nephrin and ER
Stress Proteins in Anti-GBM Nephritis—The expression of
nephrin was examined by immunofluorescence microscopy
and was then quantified. In parallel with albuminuria, anti-
GBM antibody induced a decrease in nephrin expression in
both WT and iPLA2 KO mice; nephrin expression tended to
be lower in iPLA2 KO mice, compared with WT, but the dif-
ference did not reach statistical significance (Fig. 9,A andC). By
immunoblotting, expression of themature form of nephrin was
reduced markedly in anti-GBM nephritis but comparably in
WT and iPLA2KOmice (Fig. 10,A (top nephrin band) and B).
Furthermore, the amount of mature nephrin (top band) was
reduced significantly relative to the ER form (bottom band) in
anti-GBMnephriticmice (Fig. 10,A andC). These results imply
that in anti-GBM nephritis, there is defective glycosylation of
nephrin due to ER dysfunction, although this appears to be
largely independent of iPLA2.
To further address the role of iPLA2 in ER function in vivo,
wemonitored the unfolded protein response (i.e. changes in the
expression of ER chaperones after induction of anti-GBM
nephritis). Glomerular GRP94 and GRP78 (BiP) were up-regu-
lated significantly in theKOanti-GBMmice but not inWT (Fig.
10, A, D, and E). There were no consistent changes in CHOP
(CCAAT/enhancer-binding protein homologous protein)
among groups (results not shown). These results imply that
deletion of iPLA2 in the context of glomerulonephritis leads to
amplification of the adaptive unfolded protein response. The
dose of anti-GBM antibody used in this study was low, allowing
us to ascertain differences in albuminuria between iPLA2 and
WT mice. At substantially higher doses of antibody, WT mice
with anti-GBM nephritis also show comparable increases in
glomerular expression of GRP94 and BiP (results not shown).
However, at these higher doses, albuminuria is massive and
does not allow for the study of iPLA2 effects.
Mitochondrial Injury Enhances Complement-mediated
Cytotoxicity—The primary pathological finding in aging
iPLA2KOmice ismitochondrial damage in podocytes (Fig. 2).
Compared with WT, iPLA2 KO mice (age 3 months) showed
greater albuminuria and podocyte injury after induction of
anti-GBM nephritis (Figs. 7A and 8), but mitochondrial ultra-
structural damage in the podocytes was not observed. Never-
theless, to determine whether enhanced complement-medi-
ated podocyte injury in anti-GBM nephritis in the iPLA2 KO
mice may have been associated with underlying mitochondrial
dysfunction, we examined the role of the mitochondria in
complement-dependent cytolysis in cultured GECs. We pre-
treated GECs with antimycin A to impair mitochondrial func-
tion. Then both untreated and antimycin A-treated GECs were
FIGURE 7. iPLA2 deletion exacerbates albuminuria in anti-GBM nephri-
tis.Nephritis was induced inWT and iPLA2 KOmice (3–4months of age) via
single intravenous injection of sheep anti-rat GBMantiserum (aGBM). Control
mice received saline. The urinary albumin/creatinine ratio was measured
before and 24 h after the injection. A, after the induction of anti-GBM nephri-
tis, iPLA2 KO mice had greater albuminuria compared with WT. *, p 0.05,
iPLA2 KO anti-GBM versusWT anti-GBM. KO anti-GBM, n 7mice (4 females
and 3 males); WT anti-GBM, n 7 mice (2 females and 5 males); KO control,
n 4mice;WT control,n 4mice.B, immunofluorescence staining for sheep
(Sh) anti-GBM IgG andmouse complement C3 inmice with anti-GBM nephri-
tis (at 24 h). There is bright glomerular fluorescence staining for sheep IgG in
both WT and iPLA2 KO mice. Fainter glomerular C3 staining was present in
both groups of mice. The C3 staining of Bowman’s capsule (surrounding the
glomerulus) is observed in normal mouse kidneys and is not due to the
administration of anti-GBM antibody. Bar, 20 m. C, quantification of anti-
GBM antibody and complement C3 deposition (fluorescence intensity) in
arbitrary units shows no significance differences between groups. Error bars,
S.E.
Podocyte Injury in iPLA2 Knock-outMice
JULY 8, 2016•VOLUME 291•NUMBER 28 JOURNAL OF BIOLOGICAL CHEMISTRY 14477
 at W
ashington U









incubatedwith antibody and complement, and cytotoxicity was
monitored by release of LDH. As expected, complement-medi-
ated cytolysis increased with serially increasing doses of com-
plement, and pretreatment of cells with antimycin A enhanced
complement-mediated cytolysis at every dose (Fig. 11). For
comparison, in analogous experiments, GECs were pretreated
with tunicamycin, which induces cytotoxic ER stress (21).
Tunicamycin did not, however, enhance complement cytotoly-
sis (data not shown). These results indicate that mitochondrial
dysfunction in culturedGECs enhances complement-mediated
cytotoxicity and support the view that exacerbation of GEC
injury in anti-GBM nephritis in the iPLA2 KOmice was asso-
ciated with underlying mitochondrial dysfunction.
Discussion
In this study, we demonstrated that deletion of iPLA2
resulted in striking mitochondrial abnormalities in GECs/
podocytes of 10–11-month-oldmice (Fig. 2). These ultrastruc-
tural abnormalitieswerewidespread and included disruption of
membranes, loss of cristae, fission, and aggregation (Fig. 2).
Aging iPLA2 KO mice also demonstrated podocyte plasma
membrane damage and slight but significant widening of foot
processes compared with WT (Fig. 2). Expression of synap-
topodin was lower in iPLA2 KO glomeruli (Figs. 3 and 4), and
therewas a25%decrease in the number ofWT1-positive cells
in iPLA2KO glomeruli compared with control (Fig. 3), imply-
ing that deletion of iPLA2 induced a loss of podocytes. In asso-
ciation withmitochondrial damage, phosphorylation of AMPK
was increased in iPLA2 KO glomeruli (Fig. 4), consistent with
reduced ATP generation by mitochondria in KO podocytes
leading to podocyte injury. In the aging iPLA2 KOmice, some
podocytes contained prominent autophagic vacuoles (Fig. 2).
There was also an increase in the glomerular ratio of LC3-II/
LC3-I protein expression in KOmice, in keeping with accumu-
lation of autophagic vacuoles (Fig. 4). Surprisingly, the ultra-
structural abnormalities in aging podocyteswere not associated
with development of albuminuria (Fig. 1) or renal failure,
although these could potentially appear at amore advanced age.
Studies in cultured GECs derived from WT and iPLA2 KO
mice showed that deletion of iPLA2 impaired mitochondrial
function and enhanced autophagy (Figs. 5 and 6). Indeed, the
clustering ofmitochondria in the perinuclear regions of cells (as
observed in iPLA2KOGECs) is reported to be associated with
autophagy (36). Thus, the GEC culture studies recapitulate the
phenotype in vivo and support the functional importance of the
ultrastructural findings and low cell energy stores in iPLA2
KO glomeruli.
In cells, iPLA2 is localized at the mitochondria, ER, and
peroxisomes (3). There are several variants of iPLA2, and sub-
cellular localization may, at least in part, depend on the variant
expressed in the specific cell type (3, 20, 37). Previously, we
demonstrated that iPLA2 mRNA and protein of 88 kDa are
FIGURE 8. iPLA2 deletion exacerbates abnormalities in podocyte ultra-
structure in anti-GBM nephritis. Kidneys of four albuminuric mice (two
iPLA2 KO and twoWT; 3–5 glomeruli/mouse) and three controlmice (saline-
treated groups) were examined by electron microscopy. A, an iPLA2 KO
mouse (age 3 months) injected with saline shows normal podocyte ultra-
structure. Foot processes, cell bodies, and intracellular organelles appear
intact (bar, 500 nm). B, WT mouse (age 3 months) injected with anti-GBM
antibody. In this electron micrograph, podocyte foot processes appear wid-
enedwith segmental effacement. There is some villous transformation of the
podocyte plasma membranes. C, iPLA2 KO mouse (age 3 months) injected
with anti-GBM antibody. Podocyte cell bodies appear swollen, and the cell
membranes show marked villous transformation and microvesiculation.
Podocyte foot processes are almost completely effaced. D, quantification of
foot process width in iPLA2-KO and WT mice. *, p  0.0001 KO/anti-GBM
versus other groups, 9–36 measurements/group. Error bars, S.E.
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expressed in the glomerulus in vivo (19). GFP-tagged iPLA2
was localized at the ER andmitochondria in culturedGECs, and
this pattern of localization was dependent on the N-terminal
domain of iPLA2 (20). Our results in podocytes are in keeping
with previous studies, where deletion of iPLA2 in mice
resulted in mitochondrial disruption. For example, deletion of
iPLA2 induced mitochondrial dysfunction in the heart, skele-
tal muscle, liver, and brain (7, 8, 10, 11). iPLA2 KO mice dis-
played cold intolerance, a defect in mitochondrial cytochrome
oxidase, andmultiple bioenergetic dysfunctional phenotypes at
4–6 months of age (7). In skeletal muscle of 4-month-old KO
mice, there was mitochondrial dysfunction, oxidative stress,
and lipid peroxidation (11). Thesemice exhibited growth retar-
dation. iPLA2 deletion induced significant changes in mito-
chondrial phospholipid homeostasis (see below). In aging mice
(10 months), this was associated with ultrastructural evidence
for enlarged and degenerating mitochondria in the brain,
autophagy, and cognitive dysfunction (8). These studies identi-
fied an obligatory role for iPLA2 in mitochondrial structure.
Increased autophagy in podocytes of 10–11-month-old
iPLA2 KO mice (Fig. 2) may have been triggered by reduced
ATP levels and activation of AMPK (Fig. 4). Actually, AMPK
has been implicated as an important positive regulator of
autophagy (30, 31). Autophagy was less likely to have been due
to ER stress, since there was no evidence for significant ER
dysfunction in iPLA2 KO mice (Fig. 4). It has been suggested
that in podocytes, reduced ubiquitin-proteasome function
might result in increased autophagy (30, 38). We did not, how-
ever, observe any differences in polyubiquitination of glomeru-
lar proteins between iPLA2 KO and WT mice (result not
shown). Determination of whether cross-talk between these
two systems plays a mechanistic role in injury will require fur-
ther study. In iPLA2 KO podocytes, autophagy may promote
survival by improving cell energy levels. Enhanced autophagy in
podocytes as well as in the brains of iPLA2 KOmice may also
be a cytoprotectivemechanism to clear damagedmitochondria
from the cytoplasm (30, 31, 38). Based on a study in Atg5 KO
mice, autophagy appears to be a homeostatic mechanism to
maintain podocyte integrity and a protective mechanism
against aging and glomerular injury (30).
It should be noted that in contrast to podocytes, mitochon-
dria in other kidney cell types, including parietal epithelial cells
and proximal tubular epithelial cells in iPLA2 KO mice,
showed normal ultrastructure (Fig. 2). This finding in proximal
tubular epithelial cells was unexpected because the function of
these cells is highly dependent on mitochondrial energy pro-
duction, and depletion of iPLA2 in cultured proximal tubular
epithelial cells in previous studies resulted in metabolic abnor-
malities (see below) (22). In contrast to podocytes, which
appear to contain relatively few, small mitochondria, tubular
cells in vivo contain numerous, largemitochondria (Fig. 2). Per-
haps a more robust mitochondrial structure allowed the tubu-
lar cells to withstand potential damage from the deletion of
iPLA2 in vivo. Alternatively, there may be differences in
FIGURE 9. Immunofluorescence staining for WT1 and nephrin in anti-GBM nephritis. A and B, iPLA2 deletion reduced podocyte number in anti-GBM
nephritis. WT1 immunofluorescence was assessed in two WTmice without and with anti-GBM antibody and four iPLA2 KOmice (age 3–4 months), without
and with anti-GBM antibody. Bar, 20 m. B, quantification of WT1-positive nuclei per glomerulus (25–36 glomeruli/group). *, p 0.001 KO/anti-GBM versus
WT/anti-GBM. A and C, nephrin immunofluorescence intensity was assessed in iPLA2 KOmice without (n 2) and with anti-GBM antibody (n 6) and inWT
mice without (n 2) and with anti-GBM antibody (n 5). *, p 0.0001 anti-GBM versus saline (14–31 measurements/group). Error bars, S.E.
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iPLA2 variants, expression, or activation among the renal cell
types. Finally, certain cells may activate alternate mechanisms
to compensate for iPLA2 deficiency, or the podocyte, a cell
with limited proliferative capacity (12, 14), may not be able to
withstand mitochondrial damage, unlike proximal tubular
cells, which have high potential for proliferation and repair
from injury (39).
In regard to its role in lipid homeostasis, deletion of iPLA2
resulted in a decrease in cardiolipin content and altered cardi-
olipin molecular species distribution in heart and skeletal mus-
cle mitochondria, but there were no significant changes in
phospholipids and triglycerides (7, 9, 11). In brain hippocampal
lipid extracts, iPLA2 KO mice showed an increase in various
cardiolipin molecular species, increases in arachidonoyl-phos-
phatidylcholine and oxidized phosphatidylethanolamine, an
increase in ceramide, and a decrease in plasmalogen-phos-
phatidylethanolamine (8). Decreased iPLA2 expression in
cultured renal proximal tubular cells mildly enhanced phos-
phatidylcholine and phosphatidylethanolamine levels (22).
Cardiolipin is an important mitochondrial lipid, and proper
remodeling of cardiolipin is essential for efficient electron
transport chain function. Defects in cardiolipin have also been
associated with aging. Thus, abnormal cardiolipin remodeling
in iPLA2-deficient cells would be expected to result in defec-
tive electron coupling and bioenergetic inefficiency (8). It
should be noted that although distinct directional changes in
cardiolipin levels were observed in the heart and brain, mito-
chondrial function was impaired in both instances. Further-
more, disruption of iPLA2-mediated release of fatty acids may
impair important signaling that is required for mitochondrial
function (9).
The podocyte plays a key role in maintaining glomerular
permselectivity. In normal podocytes, actin filaments are the
core structural components of foot processes. Studies predom-
inantly in cell culture models suggest that podocytes require a
high energy supply to maintain various cellular functions,
including the organization of cytoskeletal and GBM proteins
(40). Condensation of the actin cytoskeleton at the base of
effaced podocyte foot processes, together with alterations in
filtration slits and displacement and disruption of slit dia-
phragms, are features of established proteinuric glomerular dis-
eases (12–14, 17). As noted above, podocyte injury was
observed in aging iPLA2 KO mice (Fig. 2), but this was not
associated with albuminuria (Fig. 1). Possibly, there was suffi-
cient mitochondrial reserve, and the podocytes were able to
maintain their permselective function. Despite the 25% loss
of podocytes, the remaining podocytes may have been able to
stretch and/or hypertrophy to compensate for the decreased
number. Actually, the loss of podocytes may have been below
the threshold required to produce extensive GBM denudation,
proteinuria, and sclerotic lesions (16, 41, 42). In another mouse
model of mitochondrial dysfunction, due to deletion of the
Mpv17 gene, which is expressed in podocytes, albuminuria and
FIGURE 10. Effect of iPLA2 on the expression of nephrin and ER stress
proteins in anti-GBM nephritis. Glomeruli were isolated from 3-month-old
WTand iPLA2KOmice thatwere treatedwith anti-GBMantibodyor saline (at
24 h). Lysates were immunoblotted as indicated. A, representative immuno-
blots. The white lines indicate reassembly of noncontiguous gel lanes. There
were no adjustmentsmade to the digital images among the lanes that would
alter the information in the panels. B–E, densitometric quantification. B and C,
anti-GBM antibody reduced expression ofmature nephrin (top nephrin band)
as well as maturation of nephrin (ratio of top to bottom band) in bothWT and
iPLA2 KOmice. B, *, p 0.02; **, p 0.01, anti-GBM versus saline (3–4 mice/
group). C, *, p 0.05; **, p 0.02 anti-GBM versus saline (3–4mice/group).D
and E, anti-GBM antibody increased expression of GRP94 and BiP (GRP78) in
iPLA2 KO mice. D, *, p  0.005 KO/anti-GBM versus KO/saline (3–4 mice/
group). E, *, p 0.02, KO/anti-GBM versus KO/saline (3–4 mice/group). Error
bars, S.E.
FIGURE 11. Mitochondrial injury enhances complement-mediated cyto-
toxicity. Cultured GECs were preincubated with or without antimycin A (10
M, 30 min). Then untreated and antimycin A-treated GECs were incubated
with anti-GEC antibody (40 min) and complement (5, 10, and 15% normal
serum; heat-inactivated serum in controls) for 40 min. Cytolysis was moni-
toredby release of LDH. *,p0.001 antimycinA versusuntreated (four exper-
iments). Antimycin A had no significant independent effect on cytolysis. Error
bars, S.E.
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mild glomerular sclerotic lesions developed only at 18 months
of age (43).
Induction of podocyte injury with anti-GBM antibody
revealed a protective phenotype of iPLA2 in young mice. In
heterologous anti-GBM nephritis, activation of complement
and assembly of C5b-9 induces podocyte “stress” (24, 34, 35).
iPLA2 KOmice with anti-GBM nephritis had increased albu-
minuria and a remarkable reduction in podocytes compared
withWTmice (Figs. 7 and 9; see below).Moreover, iPLA2KO
mice showed substantially more severe abnormalities in podo-
cyte ultrastructure, including swelling of cell bodies, marked
villous transformation, and microvesiculation of plasma mem-
branes, and almost complete foot process effacement (Fig. 8).
Although structural abnormalities in podocyte organelles were
not evident, studies in cultured GECs demonstrated that mito-
chondrial dysfunction can enhance complement-mediated
cytotoxicity (Fig. 11), implying that podocyte injury in anti-
GBMnephritis in iPLA2KOmice wasmost likely exacerbated
due to underlying mitochondrial dysfunction. The association
of podocyte mitochondrial dysfunction with proteinuria has
been reported (40). By analogy to our study, after induction of
anti-GBM nephritis in mice with mitochondrial dysfunction
(Mpv17 gene deletion), the KOmice had greater levels of albu-
minuria compared with control, although the anti-GBMmodel
employed in this study was more chronic (4 days) (43). We
focused on anti-GBM nephritis at 24 h (the phase when medi-
ation of the disease is more restricted to complement). In acute
anti-GBM nephritis, ultrastructural changes in mitochondria
may take a longer time to develop, or alternatively, the podo-
cytes with injured mitochondria may have been those lost into
the urine due to detachment from the GBM. Based on these
results, it is reasonable to conclude that iPLA2 is cytoprotec-
tive. This in vivo result is consistent with earlier studies, which
showed that increased expression of iPLA2 in cultured GECs
reduced complement-mediated GEC injury (19).
As noted above, deletion of iPLA2 resulted in a decrease in
podocyte number in aging mice (Fig. 2) and a more marked
decrease in podocytes in younger mice with anti-GBM nephri-
tis (Fig. 9). There is both experimental and clinical evidence to
support the view that podocyte apoptosis leads to glomerular
disease and proteinuria (14, 16, 41, 42). The presence of iPLA2
at the mitochondria may therefore provide an anti-apoptotic
effect in the aging kidney and in anti-GBM nephritis. A second
possibility is that loss of podocytes is due to podocyte detach-
ment from the GBM and the subsequent appearance of viable
cells in the urine (44, 45). iPLA2 deletion potentially impairs
the energy required for the production or function of proteins
involved in mediating podocyte foot process adhesion to the
GBM. Additional proof of these mechanisms will require fur-
ther study.
Although we previously showed that the presence of iPLA2
at the ER is functionally important in terms of ER signaling in
cultured GECs (21), deletion of iPLA2 in aging mice did not
lead to any apparent abnormalities in ER morphology or func-
tion (Figs. 2–4). However, glomerular expression of the ER
chaperones, BiP and GRP94, was increased in iPLA2 KOmice
with anti-GBM nephritis (Fig. 10), implying that deletion of
iPLA2 in the context of nephritis enhanced the adaptive
unfolded protein response, particularly activation of the ATF6
pathway (38, 46, 47). This result is apparently discrepant from
an earlier study,where itwas demonstrated that overexpression
of iPLA2 enhanced ATF6 activation, whereas deletion
reduced activation in cultured GECs (21). The reason for this
discrepancywill require further elucidation; however, it is likely
that multiple signaling pathways are activated by complement
in the in vivo anti-GBM nephritis model (18), and a number of
these could potentially impact the unfolded protein response.
Activation of the adaptive unfolded response in anti-GBM
nephritis is similar to experimental membranous nephropathy,
a glomerular disease mediated by complement C5b-9 (17, 38,
46).
In conclusion, the results of this study demonstrate an
important role for iPLA2 in maintaining podocyte integrity
both in the normal kidney and in glomerular disease. In the
future, modulation of iPLA2 enzymatic activity may poten-
tially represent a novel approach to limiting GEC injury and
proteinuria.
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